AI and the future of pharmaceuticals

AI is revolutionizing drug discovery — cutting timelines, reducing costs, and unlocking new frontiers in medicine. Insilico Medicine made history as the first company to advance an AI-discovered molecule into Phase II clinical trials with proven efficacy, showcasing the real-world impact of AI in pharmaceuticals.

​Join Dr. Alex Aliper, President of Insilico Medicine, as he shares the company’s journey to unicorn status, its breakthrough AI platform, Pharma.AI, AI-powered robotics lab, and how Abu Dhabi’s innovation ecosystem is fueling global biotech success.